Page last updated: 2024-09-02

tadalafil and Priapism

tadalafil has been researched along with Priapism in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Abbasi, B; Breyer, BN; Hakam, N; Lui, JL; Shaw, NM1
Gross, MS; Rezaee, ME1
Cabrini, MR; Nardozza, A1
Carrieri, G; Cormio, L; D'Altilia, N; Massenio, P; Sanguedolce, F1
Gaillard, R; Loulergue, P; Mir, O1
Fioravanti, A; Galatti, L; Giustini, SE; Polimeni, G; Salvo, F1
Hallock, M; King, SH; Strote, J; Wessells, H1
Bivalacqua, TJ; Burnett, AL; Champion, HC; Musicki, B1
Gustafsson, LE; Hallén, K; Wiklund, NP1

Reviews

1 review(s) available for tadalafil and Priapism

ArticleYear
Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors?
    The journal of sexual medicine, 2020, Volume: 17, Issue:8

    Topics: Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Priapism; Sildenafil Citrate; Tadalafil

2020

Other Studies

8 other study(ies) available for tadalafil and Priapism

ArticleYear
Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
    Andrology, 2023, Volume: 11, Issue:7

    Topics: Adolescent; Adult; Erectile Dysfunction; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Pharmacovigilance; Phosphodiesterase 5 Inhibitors; Priapism; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; World Health Organization

2023
Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism.
    Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:8

    Topics: Adult; Cyclic Nucleotide Phosphodiesterases, Type 5; Follow-Up Studies; Humans; Male; Phosphodiesterase 5 Inhibitors; Priapism; Prospective Studies; Recurrence; Secondary Prevention; Tadalafil; Young Adult

2017
Daily tadalafil for the chronic phase of stuttering priapism: a case report.
    BMC urology, 2018, May-31, Volume: 18, Issue:1

    Topics: Drug Administration Schedule; Follow-Up Studies; Humans; Male; Priapism; Tadalafil; Vasodilator Agents; Young Adult

2018
Interaction involving tadalafil and CYP3A4 inhibition by ritonavir.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:3

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbolines; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; HIV Infections; Humans; Male; Priapism; Ritonavir; Tadalafil

2011
Interaction between tadalafil and itraconazole.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1

    Topics: Antifungal Agents; Carbolines; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Humans; Itraconazole; Male; Middle Aged; Phosphodiesterase Inhibitors; Priapism; Tadalafil

2005
Tadalafil-associated priapism.
    Urology, 2005, Volume: 66, Issue:2

    Topics: Adult; Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Priapism; Tadalafil

2005
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
    Urology, 2006, Volume: 67, Issue:5

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Anemia, Sickle Cell; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Nitric Oxide; Penile Erection; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Priapism; Purines; Recurrence; Signal Transduction; Sildenafil Citrate; Sulfones; Tadalafil

2006
Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.
    British journal of pharmacology, 2007, Volume: 150, Issue:3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbolines; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth; Nitrergic Neurons; Nitric Oxide; Penis; Phosphodiesterase Inhibitors; Piperazines; Priapism; Purines; Rabbits; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride

2007